BiVictriX Therapeutics receives FDA orphan drug designation for BVX001 in AML

BiVictriX Therapeutics plc (AIM: BVX), a prominent UK-based biotechnology firm, has reached a pivotal regulatory milestone as the US Food and Drug Administration (FDA) has ... Read More